Clinical Trial Update: Comparison of Anti-Xa Activity of ENOXA ® Versus LOVENOX ® in Acute Coronary Syndrome [Phase 4]

View source ↗

Summary

Phase 4 trial comparing anti-Xa activity of ENOXA versus Lovenox in acute coronary syndrome has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• ENOXA
• Lovenox (enoxaparin)

Snippet

Sponsor: Les Laboratoires des Médicaments Stériles | Conditions: Acute Coronary Syndrome, Factor X | Phase 4 | Status: COMPLETED